DETAILS, FICTION AND CLINICAL EFFECTIVENESS OF ABBV-744 IN AML PATIENTS

In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to establish Secure dosing program. More members will likely be enrolled in the identified monotherapy dosign routine. In Segment B, members will get oral ruxolitinib and ABBV-744 is going to be provided as "add-on" therapy. In Section C, participants will get ABBV-74